• News
  • < 1 minute read

MBHB Partner Kevin Noonan discusses the potential outcomes of the ongoing CRISPR patent dispute

  • July 18, 2024

In BioSpace, MBHB Partner Kevin Noonan shares his thoughts on how the ongoing CRISPR litigation may impact future investors.  View the article.  

Practices & Technologies

Biotechnology & Pharmaceuticals
McDonnell Boehnen Hulbert & Berghoff
Youtube Linkedin-in
Search by Type
Menu
People
 
Services
Practices Technologies
Intelligence
NewsEventsSnippetsPatently-O BlogPatent Docs
Firm
Diversity & InclusionCommunityAwards & AccoladesOur Clients
Careers
Culture and Development Career Paths Diversity And Inclusion Legal Professionals Business Professionals
LocationContact Us
Menu